Vitamin D significantly reduces two inflammatory chemicals that trigger psoriasis by working directly on nerve cells, according to a 2026 laboratory study published in Experimental Dermatology. Researchers found that both regular vitamin D and a more active form decreased interleukin-6 and calcitonin gene-related peptide production in a dose-dependent manner, with the active form proving more potent. This mechanism helps explain why people with low vitamin D have worse psoriasis and why vitamin D treatments improve skin health.
Researchers discovered that vitamin D appears to reduce two inflammatory chemicals that trigger psoriasis and other skin conditions. In laboratory tests using nerve cells, both regular vitamin D and a more powerful form significantly decreased the production of interleukin-6 and calcitonin gene-related peptide, which are molecules that fuel immune system overreaction. According to Gram Research analysis, the stronger form of vitamin D worked better at stopping these inflammatory signals. This finding helps explain why people with low vitamin D tend to have worse psoriasis and why vitamin D treatments help improve skin health.
Key Statistics
A 2026 laboratory study in Experimental Dermatology found that vitamin D significantly reduced interleukin-6 production by nerve cells in a dose-dependent manner, with the active form of vitamin D being more potent than the regular form.
Research published in 2026 demonstrated that vitamin D reduced calcitonin gene-related peptide content in nerve cells and decreased IL-6 messenger RNA expression, showing vitamin D works at the genetic level to suppress inflammatory chemical production.
According to a 2026 study in Experimental Dermatology, both 25-hydroxyvitamin D3 and 1-alpha,25-dihydroxyvitamin D3 inhibited inflammatory chemical production by transformed dorsal root ganglion neurons in a dose-dependent manner.
The Quick Take
- What they studied: Whether vitamin D can reduce two inflammatory chemicals (IL-6 and CGRP) that trigger psoriasis and autoimmune skin conditions
- Who participated: Laboratory study using specially grown nerve cells from mice that behave like human nerve cells. No human participants were involved in this experiment.
- Key finding: Both forms of vitamin D significantly reduced inflammatory chemical production in a dose-dependent manner, with the active form being more powerful at stopping inflammation
- What it means for you: This research suggests vitamin D may help control psoriasis and similar conditions by calming nerve signals that trigger immune overreaction. However, this is early laboratory research, and more human studies are needed before making treatment changes. Talk to your doctor about vitamin D levels if you have psoriasis.
The Research Details
Scientists grew specialized nerve cells in the laboratory that mimic human nerve cells in the spine and body. These cells were treated with two different forms of vitamin D: regular vitamin D (25-hydroxyvitamin D3) and a more active form (1-alpha,25-dihydroxyvitamin D3). The researchers measured how much of two inflammatory chemicals the cells produced after vitamin D treatment.
The study used different doses of vitamin D to see if higher amounts worked better at reducing inflammation. After 24 and 48 hours, scientists collected the fluid around the cells and examined the cells themselves to measure inflammatory chemical levels using a standard laboratory test called ELISA.
This approach allows researchers to study specific cellular mechanisms without testing on humans first. The nerve cells used are well-established models that behave similarly to real human nerve cells, making the findings potentially relevant to understanding how vitamin D works in the body.
This research design is important because it identifies the exact mechanism by which vitamin D might help psoriasis. By studying nerve cells specifically, the researchers showed that vitamin D works directly on the nervous system to reduce inflammatory signals. This explains why vitamin D blood levels correlate with psoriasis severity and why topical vitamin D treatments help patients. Understanding the mechanism helps scientists develop better treatments.
This is a controlled laboratory study published in a peer-reviewed journal, which means other experts reviewed the methods. The study used established cell lines and standard measurement techniques, making results reproducible. However, laboratory findings do not automatically translate to human benefits. The study did not involve human participants, so real-world effectiveness remains unknown. Additional human clinical trials are needed to confirm these findings apply to actual patients.
What the Results Show
Both forms of vitamin D significantly reduced interleukin-6 (IL-6) production by nerve cells in a dose-dependent manner, meaning higher vitamin D doses produced greater reductions. The more active form of vitamin D (1-alpha,25-dihydroxyvitamin D3) was more potent at reducing IL-6 than the regular form (25-hydroxyvitamin D3).
Vitamin D also significantly reduced calcitonin gene-related peptide (CGRP) content in the cells themselves. CGRP is a neuropeptide, a chemical messenger released by nerves that promotes immune system overreaction. The dose-dependent effect means that as vitamin D concentration increased, CGRP production decreased proportionally.
Additionally, vitamin D reduced the expression of IL-6 messenger RNA (mRNA), which is the genetic instruction that tells cells to make IL-6. This shows vitamin D works at the genetic level to suppress inflammatory chemical production.
These findings are significant because IL-6 and CGRP both promote the development of T helper 17 cells, immune cells that drive psoriasis and other autoimmune skin conditions. By reducing these two chemicals, vitamin D may prevent the immune system from attacking skin cells.
The study demonstrated that vitamin D’s anti-inflammatory effect works through multiple pathways. The fact that vitamin D reduced both the production and release of inflammatory chemicals (measured in cell fluid) and the cellular content (measured inside cells) suggests vitamin D affects both how much is made and how much is released. The more active form of vitamin D consistently outperformed the regular form across all measurements, indicating that vitamin D potency matters for therapeutic effect.
This research aligns with existing knowledge that vitamin D blood levels vary inversely with psoriasis severity, meaning people with low vitamin D tend to have worse psoriasis. It also supports clinical observations that topical vitamin D analogs effectively treat psoriasis. This study provides a cellular explanation for why these treatments work. Previous research showed that sensory nerves play a role in psoriasis development, and this study connects that finding to vitamin D’s mechanism of action by demonstrating vitamin D’s direct effect on nerve cells.
This is a laboratory study using mouse nerve cells, not human tissue or living people. Results in cell cultures do not always translate to human bodies, where many additional factors influence inflammation and immune response. The study did not test vitamin D’s effects on actual psoriasis lesions or in living organisms. Sample sizes for individual experiments were not specified in the abstract. The research does not address how much vitamin D a person would need to achieve these effects or whether topical or oral vitamin D would be more effective. Long-term effects and potential side effects were not studied.
The Bottom Line
This research provides moderate evidence that vitamin D may help manage psoriasis and similar autoimmune conditions by reducing inflammatory nerve signals. If you have psoriasis, discuss vitamin D supplementation or topical vitamin D treatments with your dermatologist. Maintain adequate vitamin D levels through sun exposure, diet, or supplements as recommended by your healthcare provider. Do not change psoriasis treatments based solely on this laboratory research without medical guidance.
People with psoriasis, eczema, or other autoimmune skin conditions should find this research interesting and worth discussing with their doctors. Those with low vitamin D levels and skin inflammation may benefit from vitamin D supplementation. Healthcare providers treating inflammatory skin conditions should consider this mechanism when recommending vitamin D. This research is less immediately relevant to people without autoimmune skin conditions, though adequate vitamin D remains important for overall health.
Laboratory studies typically take 6 to 10 years to translate into human treatments. If human clinical trials begin soon, it may take 5 to 10 years before new vitamin D-based treatments reach patients. People currently using vitamin D for psoriasis may see benefits within weeks to months, but this varies by individual and depends on baseline vitamin D levels.
Frequently Asked Questions
Does vitamin D help with psoriasis?
Laboratory research from 2026 shows vitamin D reduces inflammatory chemicals that trigger psoriasis by working on nerve cells. While promising, this is early-stage research. Topical vitamin D treatments are already used clinically for psoriasis. Discuss vitamin D supplementation with your dermatologist.
How does vitamin D reduce skin inflammation?
A 2026 study found vitamin D decreases interleukin-6 and calcitonin gene-related peptide, two inflammatory chemicals released by nerve cells that fuel immune overreaction in psoriasis. The active form of vitamin D worked more powerfully than regular vitamin D at suppressing these chemicals.
What form of vitamin D works best for inflammation?
Laboratory testing showed 1-alpha,25-dihydroxyvitamin D3, the active form, was more potent at reducing inflammatory chemicals than regular 25-hydroxyvitamin D3. However, this is laboratory research. Your doctor can recommend the best form and dose for your individual situation.
Can I use vitamin D to treat my psoriasis?
Topical vitamin D analogs are established psoriasis treatments. This 2026 research explains how vitamin D works at the cellular level. Before starting any new treatment, consult your dermatologist about appropriate vitamin D products, doses, and whether they suit your specific condition.
How long does it take vitamin D to help psoriasis?
This laboratory study does not address timeline in humans. Clinical experience suggests topical vitamin D treatments may show benefits within 4 to 8 weeks, but results vary. Oral vitamin D supplementation effects develop over weeks to months depending on baseline levels and dosage.
Want to Apply This Research?
- Track daily vitamin D intake (in international units or IU) and weekly psoriasis severity using a 1-to-10 scale. Record any changes in skin redness, scaling, or itching. Monitor vitamin D blood levels through annual lab tests if possible.
- Set a daily reminder to take vitamin D supplements as recommended by your doctor. Log your supplement intake in the app and note any changes in skin symptoms. If using topical vitamin D treatments, record application frequency and observe skin response over 4 to 8 weeks.
- Establish a baseline psoriasis severity score and vitamin D intake level. Check in weekly to assess skin changes and supplement adherence. Take photos of affected areas monthly to track visible improvements. Share trends with your healthcare provider at regular appointments to adjust treatment if needed.
This article summarizes laboratory research and is not medical advice. The study used nerve cells grown in a laboratory, not human participants, so findings may not directly apply to treating psoriasis in people. Do not change your psoriasis treatment or vitamin D supplementation based on this research alone. Consult your dermatologist or healthcare provider before starting new treatments, supplements, or making changes to existing psoriasis management. Individual responses to vitamin D vary based on genetics, baseline vitamin D levels, skin condition severity, and other health factors. This research is preliminary and requires human clinical trials before clinical applications can be established.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.